Skip to content

Evaluation of the therapeutic effect of acupuncture and massage on knee osteoarthritis guided by “liver, spleen and kidney are equally important, and muscles, bones and flesh are in harmony”

Evaluation of the therapeutic effect of acupuncture and massage on knee osteoarthritis guided by “liver, spleen and kidney are equally important, and muscles, bones and flesh are in harmony”

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200061356
Enrollment
Unknown
Registered
2022-06-21
Start date
2022-08-01
Completion date
Unknown
Last updated
2023-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Degenerative knee osteoarthritis

Interventions

Observation group:Acupuncture combined with massage

Sponsors

Hebei Provincial Hospital of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 75 Years

Inclusion criteria

Inclusion criteria: (1) Meet the diagnostic criteria of knee osteoarthritis; (2) VAS score = 4 points; (3) Disease onset; (4) 40 = age = 75; (5) No drugs affecting the efficacy were used 2 weeks before treatment; (6) Normal mental state and understanding ability; (7) Informed consent of patients and their families, and sign the informed consent form; (8) Approved by the hospital ethics committee.

Exclusion criteria

Exclusion criteria: (1) Patients with knee joint tumor, rheumatoid, tuberculosis, suppuration and acute injury; (2) Suffering from severe skin diseases such as eczema or local skin damage of knee joint; (3) Patients with severe cardiovascular disease or severe liver and kidney insufficiency; (4) Pregnant and lactating women. Note: patients who meet any of the above conditions shall be excluded.

Design outcomes

Primary

MeasureTime frame
Visual Analogue Scale;Western Ontario and McMaster Universities Osteoarthritis index;Interleukin-1(IL-1);Interleukin-6(IL-6);matrix metalloproteinases-3(MMP-3);matrix metalloproteinases-13(MMP-13);

Countries

China

Contacts

Public ContactWang Yanjun
wangyj8055@sina.com+86 13933016908

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026